A C.D.C. panel recommends J.&J. shots restart with a label noting the risk of very rare blood clots.

The U.S. government is likely to follow the panel’s recommendation and end the pause.The U.S. government is likely to follow the panel’s recommendation and end the pause.internal-essential, Blood Clots, Vaccination and Immunization, Coronavirus (2019-nCoV), Labeling and Labels (Product), Advisory Committee on Immunization Practices, Centers for Disease Control and PreventionRead More